1. Home
  2. CNMD vs CNTA Comparison

CNMD vs CNTA Comparison

Compare CNMD & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNMD
  • CNTA
  • Stock Information
  • Founded
  • CNMD 1970
  • CNTA 2020
  • Country
  • CNMD United States
  • CNTA United Kingdom
  • Employees
  • CNMD N/A
  • CNTA N/A
  • Industry
  • CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNMD Health Care
  • CNTA Health Care
  • Exchange
  • CNMD Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • CNMD 1.7B
  • CNTA 1.6B
  • IPO Year
  • CNMD 1987
  • CNTA 2021
  • Fundamental
  • Price
  • CNMD $54.33
  • CNTA $14.07
  • Analyst Decision
  • CNMD Hold
  • CNTA Strong Buy
  • Analyst Count
  • CNMD 5
  • CNTA 10
  • Target Price
  • CNMD $62.20
  • CNTA $28.78
  • AVG Volume (30 Days)
  • CNMD 418.9K
  • CNTA 1.2M
  • Earning Date
  • CNMD 07-30-2025
  • CNTA 08-12-2025
  • Dividend Yield
  • CNMD 1.47%
  • CNTA N/A
  • EPS Growth
  • CNMD 46.38
  • CNTA N/A
  • EPS
  • CNMD 3.81
  • CNTA N/A
  • Revenue
  • CNMD $1,315,998,000.00
  • CNTA $15,000,000.00
  • Revenue This Year
  • CNMD $6.27
  • CNTA N/A
  • Revenue Next Year
  • CNMD $5.62
  • CNTA N/A
  • P/E Ratio
  • CNMD $14.26
  • CNTA N/A
  • Revenue Growth
  • CNMD 4.32
  • CNTA 118.88
  • 52 Week Low
  • CNMD $46.00
  • CNTA $8.46
  • 52 Week High
  • CNMD $78.19
  • CNTA $19.09
  • Technical
  • Relative Strength Index (RSI)
  • CNMD 49.86
  • CNTA 60.47
  • Support Level
  • CNMD $51.43
  • CNTA $12.74
  • Resistance Level
  • CNMD $55.19
  • CNTA $14.27
  • Average True Range (ATR)
  • CNMD 1.55
  • CNTA 0.66
  • MACD
  • CNMD 0.18
  • CNTA 0.12
  • Stochastic Oscillator
  • CNMD 76.74
  • CNTA 85.57

About CNMD CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: